$99.8-125k
Diabetes reversal treatment
Open for applications
Diabetes reversal treatment
201-500 employees
Open for applications
$99.8-125k
201-500 employees
To revolutionize healthcare by proving chronic diabetes is reversible in hundreds of millions of people.
Jump to section
To revolutionize healthcare by proving chronic diabetes is reversible in hundreds of millions of people.
Much of the care for type 2 diabetes has been based on control and prevention, rather than a direct reversal of the issue. Virta Health is changing that, providing patients with personalized treatment plans, virtual monitoring and patient care.
Instead of depending upon medication, which often needs to be increased over time, the company is tackling the problem at its root and takes a fundamentally different approach that is better for the patient, and more economical for insurers. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal.
Although other similar platforms such as Vida Health exist, with more than 88 million prediabetic Americans and 30 million diabetic Americans, there's a large market to share. Virta's $133 million funding round in 2021 has accelerated its efforts to drive widespread adoption of its telehealth-powered diabetes reversal treatment.
Steph
Company Specialist at Welcome to the Jungle
Apr 2021
$133m
SERIES E
Dec 2020
$65m
SERIES D
This company has top investors
Sami Inkinen
(CEO)Worked on Microsoft’s strategy team for MS Office, and as a consultant for McKinsey & Company within the software, telecommunications, and government sectors. Co-founder of online real estate marketplace Trulia, serving as its COO until its IPO and eventual sale to Zillow Group.
Software Engineering
Operations & Strategy
Finance, Legal & Compliance